Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study

CompletedOBSERVATIONAL
Enrollment

30,283

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

October 31, 2018

Conditions
Safety SurveillanceAdverse Drug EventsAdverse Drug ReactionsSevere Adverse EventsSevere Adverse Reactions
Interventions
DRUG

Compound Kuh-seng Injection

Compound Kuh-seng Injection is a kind of natural compound injection extracted from Chinese herbs Kuh-seng (Radix Sophorae Flavescentis) and Rhizoma Heterosmilacis Japonicae. The major bioactive ingredients include oxymatrine,sophocarpidine, matrine, flavonoid etc.

Trial Locations (29)

250022

Shandong Provincial Western Hospital, Jinan

255020

Central Hospital of Zibo, Zibo

261041

Weifang No.2 People's Hospital, Weifang

264299

Weihai Municipal Hospital, Weihai

266031

Qingdao Center Hospital, Qingdao

271000

Tai'an Central Hospital, Tai’an

271002

The 88th Hospital of People's Liberation Army, Tai’an

271200

People's Hospital of Xintai City, Tai’an

300060

Tianjin medical university cancer institute & hosptial, Tianjin

450003

People's Hospital of Zhengzhou, Zhengzhou

450008

Henan Cancer Hospital, Zhengzhou

451199

The First Hospital of Henan College of Traditional Chinese Medicine, Zhengzhou

453000

Xinxiang Central Hospital, Xinxiang

453199

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

464000

Xinyang Central Hospital, Xinyang

471000

The First Affiliated Hospital of Henan University of Science & Technology, Luoyang

471009

Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang

475001

Henan University Huaihe Hospital, Kaifeng

610017

Chengdu Second People's Hospital, Chengdu

610041

AVIC 363 Hospital, Chengdu

610072

Teaching Hospital of Chengdu University of T.C.M., Chengdu

644000

The Second People's Hospital of Yibin, Yibin

056001

HanDan Central Hospital, Handan

056002

Handan First Hospital, Handan

050082

Bai Qiu'en International Peace Hospital, Shijiazhuang

048006

Jincheng General Hospital, Jincheng

041099

The Fourth People's Hospital of Linfen, Linfen

030012

Traditional Chinese Hospital of Shanxi, Taiyuan

044099

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
collaborator

Shanxi Zhendong pharmaceutical Co. LTD.

UNKNOWN

lead

Zhong Wang

OTHER

NCT02239237 - Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study | Biotech Hunter | Biotech Hunter